AbbVie Buys Back $5B Stock As Pharmacyclics Deal Sealed

AbbVie Inc. said Wednesday that it is buying $5 billion of its stock in an accelerated deal, following through on a plan to repurchase equity issued for its just-completed $21 billion...

Already a subscriber? Click here to view full article